A detailed history of Two Sigma Investments, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 299,531 shares of BMRN stock, worth $19.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
299,531
Previous 83,500 258.72%
Holding current value
$19.8 Million
Previous $6.87 Million 206.28%
% of portfolio
0.05%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$69.02 - $93.84 $2.82 Million - $3.84 Million
-40,919 Reduced 12.02%
299,531 $21.1 Million
Q2 2024

Aug 14, 2024

SELL
$74.43 - $92.22 $26.8 Million - $33.2 Million
-360,049 Reduced 51.4%
340,450 $28 Million
Q1 2024

May 15, 2024

BUY
$83.81 - $99.0 $24 Million - $28.4 Million
286,534 Added 69.22%
700,499 $61.2 Million
Q4 2023

Feb 14, 2024

SELL
$76.22 - $98.51 $7.62 Million - $9.85 Million
-100,033 Reduced 19.46%
413,965 $39.9 Million
Q3 2023

Nov 14, 2023

BUY
$85.07 - $94.48 $7.21 Million - $8.01 Million
84,810 Added 19.76%
513,998 $45.5 Million
Q2 2023

Aug 14, 2023

SELL
$86.68 - $100.3 $36.5 Million - $42.3 Million
-421,626 Reduced 49.56%
429,188 $37.2 Million
Q1 2023

May 15, 2023

BUY
$87.74 - $117.27 $7.41 Million - $9.9 Million
84,442 Added 11.02%
850,814 $82.7 Million
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $27.2 Million - $36.5 Million
336,437 Added 78.25%
766,372 $79.3 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $26.9 Million - $31.8 Million
327,581 Added 320.05%
429,935 $36.4 Million
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $16.2 Million - $19.6 Million
-226,236 Reduced 68.85%
102,354 $8.48 Million
Q1 2022

May 16, 2022

SELL
$74.28 - $92.69 $2.43 Million - $3.04 Million
-32,761 Reduced 9.07%
328,590 $25.3 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $19.2 Million - $24.5 Million
267,425 Added 284.72%
361,351 $31.9 Million
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $493,482 - $564,102
-6,600 Reduced 6.57%
93,926 $7.26 Million
Q2 2021

Aug 16, 2021

BUY
$75.51 - $84.79 $2.79 Million - $3.13 Million
36,890 Added 57.97%
100,526 $8.39 Million
Q1 2020

May 15, 2020

SELL
$71.37 - $96.85 $9.8 Million - $13.3 Million
-137,252 Reduced 68.32%
63,636 $5.38 Million
Q4 2019

Feb 14, 2020

SELL
$64.27 - $86.37 $34.6 Million - $46.5 Million
-538,012 Reduced 72.81%
200,888 $17 Million
Q3 2019

Nov 14, 2019

BUY
$67.4 - $85.11 $17.2 Million - $21.7 Million
255,449 Added 52.84%
738,900 $49.8 Million
Q2 2019

Aug 14, 2019

BUY
$80.35 - $93.9 $27 Million - $31.6 Million
336,068 Added 228.02%
483,451 $41.4 Million
Q1 2019

May 15, 2019

BUY
$84.2 - $98.62 $10.6 Million - $12.4 Million
126,018 Added 589.83%
147,383 $13.1 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $1.51 Million - $2 Million
18,849 Added 749.17%
21,365 $1.82 Million
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $236,302 - $265,991
2,516 New
2,516 $244,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.